March 24, 2014
A West Virginia federal judge ruled Friday that claims asserted by Mylan Inc. in a patent-infringement suit over Teva Pharmaceutical USA Inc.'s planned generic version of Mylan's respiratory illness drug Perforomist weren't invalid due to anticipation, obviousness or enablement.
July 17, 2013
A West Virginia federal judge ruled Wednesday that an treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s respiratory illness drug Perforomist.